Pulmocide in a $52M extension round

Health services Pharma

Investments

04 December 2022

Pulmocide (company)

Health services Pharma

Total investments received (USD): 144m

Round value (USD): 52m

Round investors: Adjuvant Capital Asahi Kasei F-Prime Capital IP Group Jeito Capital Pictet Group Vivo Capital SV Health Investors JJDC - Johnson & Johnson SR One Longwood Fund

Company: Pulmocide

Industry: Health services Pharma

Related deals

Osler Diagnostics raised $85 million in a Series C financing

Health services Pharma

Investments 06 November 2022

Pheon Therapeutics raised $68M from Forbion and Brandon Capital.

Biotech Health services Pharma

Investments 19 September 2022

F2G raised $70 million in a financing round co-led by new investors Forbion and Sofinnova Partners

Biotech Health services Pharma

Investments 01 August 2022

Menu

Pulmocide in a $52M extension round

Share:

Pulmocide (company)

Related deals

Osler Diagnostics raised $85 million in a Series C financing

Pheon Therapeutics raised $68M from Forbion and Brandon Capital.

F2G raised $70 million in a financing round co-led by new investors Forbion and Sofinnova Partners

Sidebar

Verticals

Benelux

DACH

Nordics and Baltics

Western Europe